Proinflammatory mediators stimulate neutrophil-directed angiogenesis

Archives of Surgery

Volumn 134, Issue 12, 1999, Pages 1325-1332

  McCourt, Morgan ^a   Wang, Jiang Huai ^a   Sookhai, Shastri ^a   Redmond, H Paul ^a  

^a University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; FAS ANTIGEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0344146580     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.12.1325     Document Type: Article

References (32)

1. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor-α. Proc Natl Acad Sci U S A. 1990;87:6758-6761.
2. Gasperini S, Calzetti F, Russa MP, De Gironcoli M, Cassatella MA. Regulation of GRO alpha production in human granulocytes. J Inflamm. 1995;45:143-151.
3. Miwa M, Sugatani J, Ikemura T, et al. Release of newly synthesized platelet-activating factor (PAF) from human polymorphonuclear leukocytes under in vivo conditions: contribution of PAF-releasing factor in serum. J Immunol. 1992;148: 872-880.
4. Liles WC, Van Voohis WC. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis. 1995;172:1573-1580.
5. Ericson SG, Zhao Y, Gao H, et al. Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulaling factor. Blood. 1998;91:2099-2107.
6. Taichman NS, Young S, Cruchley AT, Taylor P, Paleolog E. Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol. 1997;62:397-400.
7. Gaudry M, Bregerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood. 1997; 90:4153-4161.
8. Webb NJA, Myers CR, Watson CJ, Bottomley MJ, Brenchley P. Activated human neutrophils express vascular endothelial growth factor. Cytokine. 1998;10:254-257.
9. McNamara DA, Harmey JH, Walsh TN, Redmond HP, Bouchier-Hayes DJ. Significance of angiogenesis in cancer therapy. Br J Surg. 1998;85:1044-1055.
10. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/ vascular endothelial growth factor, microvascular permeability and angiogenesis. Am J Pathol. 1995;36:139-155.
11. Biancone L, De Martino A, Orlandi V, Conaldi P, Toniolo A, Camussi G. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J Exp Med. 1997;186:147-152.
12. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
13. Maheshwari RK, Srikantan V, Bhartiya D, Kleinman HK, Grant DS. Differential effects of interferon gamma and alpha on in vitro model of angiogenesis. J Cell Physiol. 1991;145:164-169.
14. Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF/ VEGF) in tumor biology. Cancer Metastasis Rev 1993;12:303-324.
15. Harmey JH, Dimitriadis E, Kay E, Redmond HP, Bouchier-Hayes D. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol. 1998;5:271-278.
16. Olliver V, Bentolila S, Chabbat J, Hakim J, de Prost D. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood. 1998;91:2698-2703.
17. Okuda Y, Tsurumaru K, Susuki S, et al. Hypoxia and endothelin-1 induce VEGF production in human vascular smooth muscle cells. Life Sci. 1998;63:477-484.
18. Viac J, Palacio S, Schmitt D, Claudy A. Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res. 1997;289:158-163.
19. Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer. 1998;77:956-964.
20. Takeshita S, Nakatani K, Takata Y, Kawase H, Sekine I, Yoshioka S. Interferon-gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) enhance lipopolysaccharide binding to neutrophils via CD14. Inflamm Res. 1998;47:101-103.
21. Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC. Interleukin-6 augments neutrophil cytoloxic potential via selective enhancement of elastase release. J Surg Res. 1998;76:91-94.
22. Biffl WL, Moore EE, Moore FA, Barnett CC Jr. Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. J Trauma. 1996;40: 575-578.
23. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin-6 induces the expression ot vascular endothelial growth factor. J Biol Chem. 1996;271:736-741.
24. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Bohler P. Tumor necrosis factor type alpha a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci U S A. 1987;84:5277-5281.
25. Pepper MS, Vassali JD, Orci L, Montesano R. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp Cell Res. 1993;204:356-363.
26. Howdieshell TR, Riegner C, Gupta V, et al. Normoxic wound fluid contains high levels of vascular endothelial growth factor. Ann Surg. 1998;228:707-715.
27. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase ot wound healing. Am J Pathol. 1998;152:1445-1452.
28. Nissen NN, Polverini PJ, Gamelli RL, DiPietro LA. Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. Surgery. 1996;119:457-465.
29. Asahara T, Bauters C, Zheng LP, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 1995;92(suppl 2):II365-II371.
30. Skipper D, Jeffrey MJ, Cooper AJ, Alexander P, Taylor I. Enhanced growth of tumor cells in healing colonic anastomoses and laparotomy wounds. Int J Colorectal Dis. 1989;4:172-177.
31. Kobayashi E, Yamauchi H. Interleukin-6 and a delay of neutrophil apoptosis after major surgery. Arch Surg. 1997;132:209-210.
32. Jacob AI, Goldberg PK, Bloom M, Degenshein A, Kozinn PJ. Endotoxin and bacteria in portal blood. Gastroenterology. 1977;72:1268-1270.